mGluR5
Recent articles
In deep water with Gül Dölen
A researcher's existential crisis led to a scientific breakthrough.
In deep water with Gül Dölen
A researcher's existential crisis led to a scientific breakthrough.
Plethora of protein-making machines in neurons may underlie fragile X
An overabundance of ribosomes drives an imbalance of proteins produced from long and short genetic transcripts in a mouse model of fragile X syndrome.
Plethora of protein-making machines in neurons may underlie fragile X
An overabundance of ribosomes drives an imbalance of proteins produced from long and short genetic transcripts in a mouse model of fragile X syndrome.
Fragile X theory falters on amygdala test
Activating certain receptors in the amygdala — a treatment that runs counter to a leading theory of what causes the condition — can reverse some traits in rats.
Fragile X theory falters on amygdala test
Activating certain receptors in the amygdala — a treatment that runs counter to a leading theory of what causes the condition — can reverse some traits in rats.
Elizabeth Berry-Kravis: Running a marathon for fragile X syndrome
Elizabeth Berry-Kravis has spent decades uncovering molecular clues to fragile X syndrome and crafting trials of treatments. Her efforts are paying off.
Elizabeth Berry-Kravis: Running a marathon for fragile X syndrome
Elizabeth Berry-Kravis has spent decades uncovering molecular clues to fragile X syndrome and crafting trials of treatments. Her efforts are paying off.
Fragile X researcher takes on COVID-19
Cara Westmark has spent the past year building the case that a drug designed for fragile X syndrome might help coronavirus patients, too.
Fragile X researcher takes on COVID-19
Cara Westmark has spent the past year building the case that a drug designed for fragile X syndrome might help coronavirus patients, too.
A quest for Quincy: Gene therapies come of age for some forms of autism
A gene therapy for Angelman syndrome stands at the forefront of efforts to treat autism-linked conditions that stem from single genes.
A quest for Quincy: Gene therapies come of age for some forms of autism
A gene therapy for Angelman syndrome stands at the forefront of efforts to treat autism-linked conditions that stem from single genes.
Mouse study hints at why fragile X drugs fail in trials
Drug after drug has failed in clinical trials for fragile X syndrome. A new study provides an explanation — a decrease in the drugs’ effectiveness over time — and points to a new strategy that could circumvent this problem.
Mouse study hints at why fragile X drugs fail in trials
Drug after drug has failed in clinical trials for fragile X syndrome. A new study provides an explanation — a decrease in the drugs’ effectiveness over time — and points to a new strategy that could circumvent this problem.
Fragile X syndrome’s link to autism, explained
Fragile X syndrome is a leading genetic cause of autism. People who have either condition often share certain traits, such as difficulties in social situations.
Fragile X syndrome’s link to autism, explained
Fragile X syndrome is a leading genetic cause of autism. People who have either condition often share certain traits, such as difficulties in social situations.
Newly discovered aspects of fragile X spur next wave of drugs
Many drugs for fragile X syndrome have failed in large clinical trials, but candidates that target new aspects of the condition may fare better.
Newly discovered aspects of fragile X spur next wave of drugs
Many drugs for fragile X syndrome have failed in large clinical trials, but candidates that target new aspects of the condition may fare better.
Smart genes; Neanderthal mini-brains; diabetes link and more
Autism and intelligence share genetic variants, researchers grow Neanderthal mini-brains and see overlap with autism, and maternal diabetes is an autism risk factor.
Smart genes; Neanderthal mini-brains; diabetes link and more
Autism and intelligence share genetic variants, researchers grow Neanderthal mini-brains and see overlap with autism, and maternal diabetes is an autism risk factor.
Explore more from The Transmitter
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
Viral remnant in chimpanzees silences brain gene humans still use
The retroviral insert appears to inadvertently switch off a gene involved in brain development.
Viral remnant in chimpanzees silences brain gene humans still use
The retroviral insert appears to inadvertently switch off a gene involved in brain development.
FDA website no longer warns against bogus autism therapies, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 26 January.
FDA website no longer warns against bogus autism therapies, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 26 January.